Last video

Information about Kidney Cancer

View all videos

Week Article

  • Clear-cell Renal Cell Carcinoma: Molecular Characterization of IMDC Risk Groups and Sarcomatoid Tumors

    Recent trials have suggested predictive biomarkers in advanced clear-cell renal cell carcinoma (accRCC): International Metastatic RCC Database Consortium (IMDC) good risk or angiogenic gene signature for sunitinib and IMDC intermediate/poor risk for ipilimumab-nivolumab and T-effector cell signature or sarcomatoid dedifferentiation for atezolizumab-bevacizumab. We hypothesized that earlier described molecular subtypes, ccrcc1 to ccrcc4, could provide similar information as a single generic biomarker and molecularly characterize the heterogeneous intermediate-risk group....

View all articles

About us

The LARCG (Latin American Renal Cancer Group) is a group of scientific and educational, multicentric, multidisciplinary and independent. It is not for profit, and the term of operation is indeterminate. It consists of Urologists, Pathologists and Oncologists, as well as professionals and researchers related to the field of health, belonging to Hospitals in Latin America, Spain and the United States.

Read more

Last Tweets

Congratulations to Dr. Gustavo Carvalhal for the excellent scientific program and the organization of the 37th Brazilian Congress of Urology. We are very grateful for the opportunity to show the development and results of LARCG. @StenioZequi

2

Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies #kidneycancer #kcsm https://t.co/KIFt0fUynE

First-line IO Combination Therapies in Metastatic Renal-cell carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium
#kidneycancer #VisualAbstract
@shaan_dudani @DrDanielHeng @drjeffreygraham @DrChoueiri

https://t.co/l232CLxcES

Load More...

Sponsor

Associates

You don't have permission to register